Finance

YNBY INTL(00030.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 2.69 million, YoY increase of 13.31% - NewTimeSpace
YNBY INTL(00030.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 2.69 million, YoY increase of 13.31%

NewTimeSpace News: August 14, 2026, YNBY INTL(00030.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 762.54 million, increased by 92.34% YoY.

NewTimeSpace · 2026-08-17
YNBY INTL00030.HKprofit growth
PALINDA GROUP(08179.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 1.15 million, turned into a loss from a profit YoY - NewTimeSpace
PALINDA GROUP(08179.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 1.15 million, turned into a loss from a profit YoY

NewTimeSpace News: August 14, 2026, PALINDA GROUP(08179.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 64.34 million, decreased by 0.04% YoY.

NewTimeSpace · 2026-08-17
PALINDA GROUP08179.HKturned into a loss from a profit
CH DEMETER FIN(08120.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 10.65 million, loss narrowed by 39.65% YoY - NewTimeSpace
CH DEMETER FIN(08120.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 10.65 million, loss narrowed by 39.65% YoY

NewTimeSpace News: August 14, 2026, CH DEMETER FIN(08120.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 24.35 million, decreased by 52.96% YoY.

NewTimeSpace · 2026-08-17
CH DEMETER FIN08120.HKloss narrowed
SANDS CHINA LTD(01928.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 398 million, YoY decrease of 3.63% - NewTimeSpace
SANDS CHINA LTD(01928.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 398 million, YoY decrease of 3.63%

NewTimeSpace News: August 14, 2026, SANDS CHINA LTD(01928.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 3.88 billion, increased by 11.08% YoY.

NewTimeSpace · 2026-08-17
SANDS CHINA LTD01928.HKProfit declined
NU ENVIRO(00436.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 11.71 million, loss widened by 10.23% YoY - NewTimeSpace
NU ENVIRO(00436.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 11.71 million, loss widened by 10.23% YoY

NewTimeSpace News: August 14, 2026, NU ENVIRO(00436.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 181.02 million, increased by 9.63% YoY.

NewTimeSpace · 2026-08-17
NU ENVIRO00436.HKLoss widens
SEM HLDGS(09929.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 53.41 million, turned into a loss from a profit YoY - NewTimeSpace
SEM HLDGS(09929.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 53.41 million, turned into a loss from a profit YoY

NewTimeSpace News: August 14, 2026, SEM HLDGS(09929.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 38.78 million, increased by 80% YoY.

NewTimeSpace · 2026-08-17
SEM HLDGS09929.HKturned into a loss from a profit
SING LEE(08076.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 8.44 million, loss widened by 10.22% YoY - NewTimeSpace
SING LEE(08076.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 8.44 million, loss widened by 10.22% YoY

NewTimeSpace News: August 14, 2026, SING LEE(08076.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 20.6 million, increased by 13.2% YoY.

NewTimeSpace · 2026-08-17
SING LEE08076.HKLoss widens
KAM HING INT'L(02307.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 13.74 million, YoY increase of 114.38% - NewTimeSpace
KAM HING INT'L(02307.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 13.74 million, YoY increase of 114.38%

NewTimeSpace News: August 14, 2026, KAM HING INT'L(02307.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 1.77 billion, decreased by 3.7% YoY.

NewTimeSpace · 2026-08-17
KAM HING INTL02307.HKprofit growth
XIAOCAIYUAN(00999.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 289.84 million, YoY decrease of 24.2% - NewTimeSpace
XIAOCAIYUAN(00999.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 289.84 million, YoY decrease of 24.2%

NewTimeSpace News: August 14, 2026, XIAOCAIYUAN(00999.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 2.9 billion, increased by 6.96% YoY.

NewTimeSpace · 2026-08-17
XIAOCAIYUAN00999.HKProfit declined
B&K CORP-B(02396.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 121.92 million, loss widened by 40.65% YoY - NewTimeSpace
B&K CORP-B(02396.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 121.92 million, loss widened by 40.65% YoY

NewTimeSpace News: August 14, 2026, B&K CORP-B(02396.HK) released its Interim Report for the period ended December 31, 2026.

NewTimeSpace · 2026-08-17
B&K CORP-B02396.HKLoss widens
INSILICO (03696.HK): to be included in MSCI Global Small Cap Index, effective after market close on 31 August - NewTimeSpace
INSILICO (03696.HK): to be included in MSCI Global Small Cap Index, effective after market close on 31 August

NewTimeSpace News: On 17 August 2026, InSilico Medicine (03696.HK) voluntarily announced that it will be included in the MSCI Global Small Cap Index, effective after the market close on 31 August 2026; the Company had previously been included in several major index series including CSI, Hang Seng and FTSE, and the Board expects the inclusion to raise its international profile and attract passive fund inflows.

NewTimeSpace · 2026-08-17
Insilico Medicine03696.HKMSCIIndex Inclusion
HENLIUS (02696.HK): enters global strategic partnership with Sandoz covering up to 10 biosimilar products, with upfront and milestone payments totaling up to USD 314 million - NewTimeSpace
HENLIUS (02696.HK): enters global strategic partnership with Sandoz covering up to 10 biosimilar products, with upfront and milestone payments totaling up to USD 314 million

NewTimeSpace News: On 17 August 2026, Henlius (02696.HK) announced that on 16 August 2026 it entered into a cooperation framework agreement with Sandoz, establishing a global strategic partnership covering up to 10 mAb and/or ADC biosimilar products in territories excluding Mainland China and Hong Kong, Macao and Taiwan regions of China; for the first batch of three products, upfront and milestone payments total up to USD 314 million, plus a 40% share of net sales or net profits and a USD 8 million option fee.

NewTimeSpace · 2026-08-17
HENLIUS02696.HKstrategic cooperation
HUTCHMED (00013.HK): ORPATHYS® + TAGRISSO® combination shows statistically and clinically meaningful PFS and OS improvement in MET-driven EGFR-mutated lung cancer - NewTimeSpace
HUTCHMED (00013.HK): ORPATHYS® + TAGRISSO® combination shows statistically and clinically meaningful PFS and OS improvement in MET-driven EGFR-mutated lung cancer

NewTimeSpace News: On 17 August 2026, HUTCHMED (00013.HK) announced positive topline results from the SAFFRON Phase III study of ORPATHYS® plus TAGRISSO® in MET-driven EGFR-mutated NSCLC, showing statistically significant and clinically meaningful improvements in both PFS and OS, the first global Phase III trial in this setting to show significant benefit on both endpoints; the combination was well tolerated, and the data will be shared with global regulatory authorities to support global registration of the regimen.

NewTimeSpace · 2026-08-17
HUTCHMED00013.HKClinical Trial
TSIT WING INTL(02119.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 23.7 million, YoY decrease of 4.66% - NewTimeSpace
TSIT WING INTL(02119.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 23.7 million, YoY decrease of 4.66%

NewTimeSpace News: August 14, 2026, TSIT WING INTL(02119.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 398.43 million, increased by 4.73% YoY.

NewTimeSpace · 2026-08-17
TSIT WING INTL02119.HKProfit declined
SINOFORTUNE FIN(08123.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 5.91 million, turned into a loss from a profit YoY - NewTimeSpace
SINOFORTUNE FIN(08123.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 5.91 million, turned into a loss from a profit YoY

NewTimeSpace News: August 14, 2026, SINOFORTUNE FIN(08123.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 46.06 million, increased by 923.35% YoY.

NewTimeSpace · 2026-08-17
SINOFORTUNE FIN08123.HKturned into a loss from a profit
TIANAN MEDICARE(00383.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 47.36 million, YoY increase of 295.37% - NewTimeSpace
TIANAN MEDICARE(00383.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 47.36 million, YoY increase of 295.37%

NewTimeSpace News: August 14, 2026, TIANAN MEDICARE(00383.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 827.1 million, increased by 5.61% YoY.

NewTimeSpace · 2026-08-17
TIANAN MEDICARE00383.HKprofit growth
Previous1..7071 727374..273     273 pages total